» Articles » PMID: 16803994

Oxidative Stress Induces Intralysosomal Accumulation of Alzheimer Amyloid Beta-protein in Cultured Neuroblastoma Cells

Overview
Specialty Science
Date 2006 Jun 29
PMID 16803994
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress is considered important for the pathogenesis of Alzheimer's disease (AD), which is characterized by the formation of extracellular senile plaques, mainly composed of amyloid beta-protein (Abeta). Abeta also accumulates within AD neurons and is believed to exert cellular toxicity through lysosomal labilization. We report that the exposure of human neuroblastoma cells to hyperoxia (40% vs. 8% ambient oxygen) induced the accumulation of large (over 1 microM) Abeta-containing lysosomes, which were not typical of control cells, showing a distinct localization of Abeta and lysosomal markers. An inhibitor of autophagy, 3-methyladenine, suppressed the effect of hyperoxia. The results suggest a link between the involvement of oxidative stress and lysosomes in AD.

Citing Articles

Analysis of ADORA2A rs5760423 and CYP1A2 rs762551 Genetic Variants in Patients with Alzheimer's Disease.

Siokas V, Mouliou D, Liampas I, Aloizou A, Folia V, Zoupa E Int J Mol Sci. 2022; 23(22).

PMID: 36430879 PMC: 9697425. DOI: 10.3390/ijms232214400.


Cell senescence altered the miRNA expression profile in porcine angular aqueous plexus cells.

Tan C, Yang Y, Song M, Cao Z, Sun X, Lei Y Mol Vis. 2020; 26:76-90.

PMID: 32165828 PMC: 7043640.


The Neuroprotective Effects of Melatonin: Possible Role in the Pathophysiology of Neuropsychiatric Disease.

Lee J, Woo Y, Park S, Seog D, Seo M, Bahk W Brain Sci. 2019; 9(10).

PMID: 31640239 PMC: 6826722. DOI: 10.3390/brainsci9100285.


Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental Validation.

Yao F, Zhang K, Zhang Y, Guo Y, Li A, Xiao S Front Neurol. 2019; 9:1158.

PMID: 30671019 PMC: 6331438. DOI: 10.3389/fneur.2018.01158.


The neuroprotective role of melatonin in neurological disorders.

Alghamdi B J Neurosci Res. 2018; 96(7):1136-1149.

PMID: 29498103 PMC: 6001545. DOI: 10.1002/jnr.24220.